cobaltous chloride has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, TH; Tsui, L | 1 |
| Bauskin, AR; Breit, SN; Brown, DA; Jiang, L; Luo, XW; Wu, L | 1 |
2 other study(ies) available for cobaltous chloride and Atherosclerosis
| Article | Year |
|---|---|
Cobalt Chloride Induces Macrophage Foam Cell Formation: A Chemical Hypoxia Model for Anti-Atherosclerotic Drug Screening.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell Hypoxia; Cells, Cultured; Cobalt; Drug Evaluation, Preclinical; Macrophages; Mice; Models, Biological; RAW 264.7 Cells | 2021 |
The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores.
Topics: Arthritis, Rheumatoid; Atherosclerosis; Cell Differentiation; Cell Hypoxia; Cloning, Molecular; Cobalt; Growth Differentiation Factor 15; Humans; Immunization; Lipopolysaccharides; Macrophages; Neoplasms; Protein Processing, Post-Translational; Secretory Pathway; Transforming Growth Factor beta; Transgenes; Tretinoin; U937 Cells | 2010 |